Marshall Wace
IRMD icon

Marshall Wace’s iRadimed IRMD Stock Holding History

Marshall Wace’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,531
Closed -$463K – 2730
2024
Q2 		$463K Buy
+10,531
New +$448K ﹤0.01% 1993
2022
Q2 		– Sell
-5,459
Closed -$246K – 3642
2022
Q1 		$246K Sell
5,459
-29,121
-84% -$1.35M ﹤0.01% 3023
2021
Q4 		$1.6M Buy
+34,580
New +$1.4M ﹤0.01% 2187
2020
Q2 		– Sell
-37,904
Closed -$809K – 1749
2020
Q1 		$809K Sell
37,904
-28,318
-43% -$674K 0.01% 855
2019
Q4 		$1.55M Sell
66,222
-36,336
-35% -$849K 0.01% 875
2019
Q3 		$2.16M Buy
102,558
+28,142
+38% +$574K 0.02% 745
2019
Q2 		$1.52M Buy
74,416
+65,819
+766% +$1.55M 0.01% 845
2019
Q1 		$241K Buy
+8,597
New +$225K ﹤0.01% 1304

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace's IRMD Position: Q3 2024 in Review

Marshall Wace sold out of iRadimed (IRMD) in Q3 2024, closing a stake of 10,531 shares — an estimated $463K sold.

Marshall Wace first reported a position in IRMD in Q1 2019 and held it in 8 quarters. The position peaked at $2.16M in Q3 2019. 144 funds tracked by Wall St. Rank hold IRMD as of Q3 2024.

  • Marshall Wace reported no remaining iRadimed position as of Q3 2024 after selling out during the quarter.
  • Marshall Wace sold 10,531 iRadimed shares in Q3 2024, an estimated $463K.
  • Marshall Wace first reported a position in iRadimed in Q1 2019 and held it in 8 quarters.
  • Marshall Wace's iRadimed position peaked at $2.16M in Q3 2019.
  • 144 funds tracked by Wall St. Rank held iRadimed as of Q3 2024.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.